HUDSON VALLEY INVESTMENT ADVISORS INC /ADV - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 1 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2019$10,00020,0000.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Benin Management CORP 14,300$7,0000.00%
NORTHWEST WEALTH MANAGEMENT, LLC 4,000$2,0000.00%
Virtu Financial LLC 62,036$32,0000.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 20,000$10,0000.00%
Northeast Financial Consultants Inc 15,000$8,0000.00%
FRONTIER INVESTMENT MGMT CO 40,000$20,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 103,100$53,0000.00%
WEDBUSH SECURITIES INC 25,500$13,0000.00%
WELLS FARGO & COMPANY/MN 206$00.00%
NORTHERN TRUST CORP 99,691$51,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders